FXI concentrate use and risk of thrombosis-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

FXI concentrate use and risk of thrombosis

Published:2014-05-02 Issue:4 Volume:20 Page:e349-e351
ISSN:1351-8216
Container-title:Haemophilia
language:en
Short-container-title:Haemophilia

Author:

Bolton-Maggs P.¹,Goudemand J.²,Hermans C.³,Makris M.⁴,de Moerloose P.⁵

Affiliation:

1. SHOT Office; Manchester Blood Centre; Plymouth Grove; Manchester UK

2. Department of Haematology; Lille University Hospital; Hopital Cardiologique; Lille France

3. Division of Haematology; Haemostasis and Thrombosis Unit; Haemophilia Clinic; St-Luc University Hospital; Brussels Belgium

4. Department of Cardiovascular Science; University of Sheffield and Sheffield Haemophilia and Thrombosis Centre; Sheffield UK

5. Angiology and Haemostasis Division; University Hospital Geneva; Geneva Switzerland

Publisher

Wiley

Subject

Genetics (clinical),Hematology,General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/hae.12457/fullpdf

Reference10 articles.

1. Factor XI deficiency-resolving the enigma?;Bolton Maggs;Hematology Am Soc Hematol Edu Program,2009

2. Classification of rare bleeding disorders (RBDs) based on the association between coagulant factor activity and clinical bleeding severity;Peyvandi;J Thromb Haemost,2012

3. Thrombin generation in patients with factor XI deficiency and clinical bleeding risk;Rugeri;Haemophilia,2010

4. Biological determinants of bleeding in patients with heterozygous factor XI deficiency;Gueguen;Br J Haematol,2012

5. Thrombogenic potential of factor XI concentrate;Bolton-Maggs;Lancet,1994

Cited by 46 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Rare bleeding disorders: Real-world data from a Spanish tertiary hospital;Blood Cells, Molecules, and Diseases;2024-05

2. The foundation for investigating factor XI as a target for inhibition in human cardiovascular disease;Journal of Thrombosis and Thrombolysis;2024-04-25

3. Factor XI deficiency: phenotypic age-related considerations and clinical approach towards bleeding risk assessment;Blood;2024-04-11

4. Abelacimab in Cancer-Associated Thrombosis: The Right Drug at the Right Time for the Right Purpose. A Comprehensive Review;Reviews in Cardiovascular Medicine;2023-10-19

5. A new strategy for anticoagulation: The factor XI inhibitors;European Journal of Internal Medicine;2023-10

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3